Serum Bilirubin Levels in Normal-tension Glaucoma

Status Completed

Clinical Trial Summary

Purpose: To analyze the relationship between normal-tension glaucoma (NTG) and serum bilirubin levels.

Materials and Methods: This research included 38 patients with NTG and 38 healthy controls with similar age and sex distribution, for a total of 76 subjects. Serum samples were taken from all of the subjects, direct serum bilirubin, indirect serum bilirubin and the total serum bilirubin were measured.

Clinical Trial Description

This is a retrospective study of cases with recently or previously diagnosed NTG who were admitted to our clinic between 2010 and 2017. This study included 38 patients with NTG and 38 healthy controls with similar age and sex distribution, for a total of 76 subjects. Written informed consent was obtained from all of the participants. The study was approved by the institutional review board of the hospital and adhered to the tenets of the Declaration of Helsinki.

A complete ophthalmic examination including best-corrected visual acuity, slit-lamp biomicroscopy, Goldmann applanation tonometry (AT 900, Haag-Streit Diagnostics, Koeniz, CH), corneal thickness evaluation (Pachymeter SP-3000, Tomey Corporation, Nagoya, JP), gonioscopy and ophthalmoscopy was performed in all NTG cases. Additionally, optical coherence tomography (OCT RS-3000 Lite, NIDEK Corporation, Tokyo, JP) measurement of the peripapillary retinal nerve fibre layer thickness, and Humprey visual field testing (Carl-Zeiss Meditec, Dublin, CA) were also performed.

NTG was diagnosed based on a clinical examination showing a normal IOP (corrected for corneal thickness), thinning of the peripapillary retinal nerve fibre layer, optic nerve damage, and characteristic glaucomatous visual field defects. The exclusion criteria included other forms of glaucoma such as primary open-angle glaucoma, primary closed-angle glaucoma, pigmentary glaucoma and exfoliative glaucoma. Patients who had active systemic diseases such as those affecting the liver, biliary system, pancreas and kidney and infectious diseases or malignant tumours that could influence the serum bilirubin concentrations were also excluded.

Fasting blood samples were taken from each participant to measure direct bilirubin, indirect bilirubin, and the total serum bilirubin concentrations. The direct bilirubin and total bilirubin concentrations were measured with an Architect C16000 Clinical Chemistry Analyzer (Abbott Laboratories, Abbott Park, IL, USA), using its original kits, and the indirect bilirubin concentrations were calculated by the following formula: indirect bilirubin = total bilirubin - direct bilirubin.

All the data were compiled into a computer file, and Statistical Package for Social Sciences for Windows 22.0 was used to perform the statistical analysis. Student's t test or the Mann-Whitney U test were used to compare the mean values between the two groups, after the evaluation of the data for a normal distribution using the Kolmogorov-Smirnov test. A p value less than 0.05 was considered statistically significant. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03387306
Study type	Observational
Source	Trakya University
Contact
Status	Completed
Phase	N/A
Start date	January 2010
Completion date	April 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01995136` - Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma	Phase 4
Completed	`NCT00706056` - A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure	N/A
Not yet recruiting	`NCT05075369` - Water Drinking Test Study and Disc Hemorrhages in Normal Tension Glaucoma	N/A
Completed	`NCT01769521` - Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG	N/A
Recruiting	`NCT01446497` - Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma	Phase 4
Terminated	`NCT01864317` - Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging	Phase 2
Not yet recruiting	`NCT00739154` - Protective Effect of Phenytoin on Glaucoma	N/A
Recruiting	`NCT03761992` - Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTG	N/A
Recruiting	`NCT05371977` - Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma	N/A
Completed	`NCT03106532` - Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma	Phase 2
Completed	`NCT01488032` - Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma	N/A
Completed	`NCT01175902` - Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma	N/A
Completed	`NCT00570362` - Systemic Glutathione Level in Normal Tension Glaucoma	N/A
Recruiting	`NCT06449352` - Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost	Phase 4
Not yet recruiting	`NCT06023927` - Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
Completed	`NCT04475900` - Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Completed	`NCT02863705` - Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)	Phase 4
Completed	`NCT00175786` - Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma	N/A
Completed	`NCT03323164` - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study	Phase 4
Completed	`NCT04014933` - Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System